ANIXA BIOSCIENCES, INC. Accrued Payroll Taxes
ANIXA BIOSCIENCES, INC. (ANIX) had Accrued Payroll Taxes of $718.00 thousand as of 2024-04-30, per its 10-Q filed 2024-06-04.
Discontinued › Notes › Payables and Accruals › Accrued Liabilities
us-gaap:AccruedPayrollTaxesCurrentAndNoncurrent · last filed 2024-06-04
- 2024-04-30: Accrued Payroll Taxes $718.00K.
- 2024-01-31: Accrued Payroll Taxes $552.00K.
- 2023-10-31: Accrued Payroll Taxes $1.11M.
- 2023-07-31: Accrued Payroll Taxes $977.00K.
| Period end | Accrued Payroll Taxes | Accrued Payroll Taxes as first filed |
|---|---|---|
| 2024-04-30 | $718.00K 10-Q · filed 2024-06-04 | |
| 2024-01-31 | $552.00K 10-Q · filed 2024-03-12 | |
| 2023-10-31 | $1.11M 10-Q · filed 2024-06-04 | |
| 2023-07-31 | $977.00K 10-Q · filed 2023-09-06 | |
| 2023-04-30 | $663.00K 10-Q · filed 2023-06-14 | |
| 2023-01-31 | $461.00K 10-Q · filed 2023-03-17 | |
| 2022-10-31 | $1.14M 10-K · filed 2024-01-16 | |
| 2022-07-31 | $621.00K 10-Q · filed 2022-09-09 | |
| 2022-04-30 | $477.00K 10-Q · filed 2022-06-10 | |
| 2022-01-31 | $603.00K 10-Q · filed 2022-03-11 | |
| 2021-10-31 | $492.00K 10-K · filed 2023-01-04 | $491.95K 10-K · filed 2022-01-04 |
| 2021-07-31 | $392.38K 10-Q · filed 2021-09-01 | |
| 2021-04-30 | $310.64K 10-Q · filed 2021-06-10 | |
| 2021-01-31 | $228.16K 10-Q · filed 2021-03-11 | |
| 2020-10-31 | $415.33K 10-K · filed 2022-01-04 | |
| 2020-07-31 | $238.56K 10-Q · filed 2020-09-08 | |
| 2019-10-31 | $72.85K 10-K · filed 2021-01-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |